{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:31Z","timestamp":1786119391968,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/mop.0b013e328332c68f","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T03:38:28Z","timestamp":1258429108000},"page":"709-716","source":"Crossref","is-referenced-by-count":72,"title":["Osteogenesis imperfecta: questions and answers"],"prefix":"10.1097","volume":"21","author":[{"given":"Jay R","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Sponsellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1074\/jbc.M801982200","article-title":"Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta","volume":"283","author":"Pace","year":"2008","journal-title":"J Biol Chem"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1073\/pnas.95.4.1681","article-title":"Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing","volume":"95","author":"K\u00f6rkk\u00f6","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddn374","article-title":"Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype\u2013phenotype relationships","volume":"18","author":"Bodian","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","article-title":"CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta","volume":"127","author":"Morello","year":"2006","journal-title":"Cell"},{"key":"R5-4-20210206","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/(SICI)1097-0223(199706)17:6<559::AID-PD111>3.0.CO;2-G","article-title":"Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: a review of biochemical and molecular studies completed in 129 pregnancies","volume":"17","author":"Pepin","year":"1997","journal-title":"Prenat Diagn"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcu.20360","article-title":"Fetus with osteogenesis imperfecta presenting as increased nuchal translucency thickness in the first trimester","volume":"36","author":"Hsieh","year":"2008","journal-title":"J Clin Ultrasound"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum Mutat"},{"key":"R9-4-20210206","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1021\/bi800026k","article-title":"Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations","volume":"47","author":"Bodian","year":"2008","journal-title":"Biochemistry"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.30.6.492","article-title":"Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible","volume":"30","author":"Wallis","year":"1993","journal-title":"J Med Genet"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","article-title":"Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease","volume":"31","author":"Ward","year":"2002","journal-title":"Bone"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S8756-3282(02)00808-6","article-title":"Osteogenesis imperfecta type VII maps to the short arm of chromosome 3","volume":"31","author":"Labuda","year":"2002","journal-title":"Bone"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1056\/NEJMoa063804","article-title":"Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta","volume":"355","author":"Barnes","year":"2006","journal-title":"N Engl J Med"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","article-title":"Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta","volume":"39","author":"Cabral","year":"2007","journal-title":"Nat Genet"},{"key":"R15-4-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jmg.2008.062729","article-title":"Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation","volume":"46","author":"Willaert","year":"2009","journal-title":"J Med Genet"},{"key":"R16-4-20210206","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","article-title":"CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta","volume":"29","author":"Baldridge","year":"2008","journal-title":"Hum Mutat"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/ajmg.a.32508","article-title":"Popcorn calcification in osteogenesis imperfecta: incidence, progression, and molecular correlation","volume":"146","author":"Obafemi","year":"2008","journal-title":"Am J Med Genet A"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.a.30231","article-title":"Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2","volume":"131","author":"Ha-Vinh","year":"2004","journal-title":"Am J Med Genet A"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1442-200X.2008.02752.x","article-title":"Cyclic pamidronate treatment in Bruck syndrome: proposal of a new modality of treatment","volume":"50","author":"Andiran","year":"2008","journal-title":"Pediatr Int"},{"key":"R20-4-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/JPEM.2009.22.1.55","article-title":"Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis","volume":"22","author":"Brown","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R21-4-20210206","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","article-title":"Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxy-terminal propeptide in type I procollagen","volume":"18","author":"Marini","year":"2003","journal-title":"J Bone Mineral Res"},{"issue":"Suppl 1","key":"R22-4-20210206","first-page":"S341","article-title":"Vitamin D deficiency in osteogenesis imperfecta","volume":"22","author":"Martin","year":"2007","journal-title":"Am J Bone Min Res"},{"key":"R23-4-20210206","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2006.03.013","article-title":"Early bisphosphonate treatment in infants with severe osteogenesis imperfecta","volume":"149","author":"Antoniazzi","year":"2006","journal-title":"J Pediatr"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/adc.2006.096552","article-title":"Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta","volume":"92","author":"Astr\u00f6m","year":"2007","journal-title":"Arch Dis Child"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J Bone Min Res"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review. 1: Bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","article-title":"Pamidronate treatment with osteogenesis imperfecta: histomorphometric effects of long term therapy","volume":"92","author":"Rauch","year":"2006","journal-title":"J Clin Endocrinol"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","article-title":"Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta","volume":"40","author":"Rauch","year":"2007","journal-title":"Bone"},{"issue":"Suppl 5","key":"R29-4-20210206","first-page":"8","article-title":"Treatment of osteogenesis imperfecta: who, why, what?","volume":"68","author":"Glorieux","year":"2007","journal-title":"Horm Res"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.ANC.0000311013.71510.41","article-title":"Osteogenesis imperfecta in the neonate","volume":"8","author":"Hackley","year":"2008","journal-title":"Adv Neonat Care"},{"key":"R31-4-20210206","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astr\u00f6m","year":"2002","journal-title":"Arch Dis Child"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R33-4-20210206","first-page":"CD005088","article-title":"Bisphosphonate therapy for osteogenesis imperfecta.","volume":"4","author":"Phillipi","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-8749.2008.03222.x","article-title":"Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review","volume":"51","author":"Castillo","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"R35-4-20210206","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta","volume":"21","author":"DiMeglio","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R36-4-20210206","first-page":"105","article-title":"Alendronate treatment in children with osteogenesis imperfecta","volume":"45","author":"Akcay","year":"2008","journal-title":"Indian Pediatr"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Residronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"J Bone Mineral Res"},{"key":"R39-4-20210206","first-page":"77","article-title":"Modern approach to osteogenesis imperfecta","volume":"12","author":"Zeitlin","year":"2003","journal-title":"J Pediatr Orthop B"},{"key":"R40-4-20210206","article-title":"Spine deformity secondary to dysplasias and other diseases","author":"Sponseller","year":"2007"},{"key":"R41-4-20210206","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nec.2007.05.004","article-title":"Spinal disorders associated with skeletal dysplasias and syndromes","volume":"18","author":"Song","year":"2007","journal-title":"Neurosurg Clin N Am"},{"key":"R42-4-20210206","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/00007632-199908150-00008","article-title":"Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta","volume":"24","author":"Widmann","year":"1999","journal-title":"Spine"},{"key":"R43-4-20210206","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s005860000165","article-title":"Operative treatment of severe scoliosis in osteogenesis imperfecta: results of 20 patients after halo traction and posterior spondylodesis with instrumentation","volume":"9","author":"Janus","year":"2000","journal-title":"Eur Spine J"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e328332c68f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:40Z","timestamp":1786039720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200912000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328332c68f","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}